Pfizer has said it does not expect to return to revenue growth until 2029, as it works to develop new blockbuster drugs, including the obesity treatments it picked up in the $10 billion (NZ$17b) acquisition of Metsera
Hims & Hers has struck a deal with Novo Nordisk to sell its medications and stop marketing compounded versions
This rare genetic condition increases cancer risk, and these medications may add to that concern
Reports from independent review sites (Clearmetabolic, Telehealth Ally, Howmuchblog) corroborate the membership-plus-medication structure and note that BBB complaints occasionally cite confusion about the billing split
Common types of GLP1 drugs The first GLP-1 medicine, Exenatide, was introduced in 2005
Common adverse effects include gastrointestinal disturbances like nausea and vomiting